|
|
View Clinical Trial (Medical Research Study)
|
Determinants of Smoking Cessation Among Latinos - NCT01008748-77030 (Clinical Trial 399709)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy399709.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Houston |
|
State:
|
|
TX |
| Zip Code: |
|
77030 |
| Conditions: |
|
Smoking Cessation |
| Purpose: |
|
The goal of this study is to learn how neighborhood and individual factors affect the
ability to stop smoking among Spanish-speaking Mexican American (MA) smokers who want to
quit smoking.
|
| Study summary: |
|
If you agree to take part in this study, you will receive treatment to help you quit
smoking, including written self-help materials, counseling, and a supply of the nicotine
patch for 4 weeks. Over the next 6 months, you will visit M. D. Anderson 5 times during
this study. You will also be called 3 times for smoking cessation counseling during this
study.
Study Visits:
First (Orientation) Visit:
You will be asked about your feelings and moods, as well as how many cigarettes you smoke.
You will fill out questionnaires on a computer. The questionnaires will be about your mood,
stress level, and smoking-related issues. They should take about 1 hour and 30 minutes to
complete.
You will complete a breath test. For the breath test, you will blow into a tube that's
attached to a machine that is used to estimate the amount of tobacco smoke that you inhale.
You will give a saliva sample at this visit. To collect a saliva sample, you will place a
piece of cotton in your mouth for 3 minutes. The saliva sample is used to check the amount
of cotinine in the body. Cotinine is a chemical that is produced in your saliva when your
body breaks down nicotine.
You will be asked to provide 1 buccal (cheek cells) sample that will be collected using
mouthwash. Researchers will perform genetic tests with these samples to look for genes that
control the production and use of neurotransmitters, naturally occurring chemical messengers
in the brain. People with certain genes may have a more difficult time quitting smoking,
because of the way nicotine affects these chemicals. Genetic information obtained will not
be provided to you.
Second (Baseline) Visit:
Your second visit (Baseline) will occur 1 week before your Quit date visit. You will fill
out questionnaires on a computer. The questionnaires will be about your, stress level,
social support and smoking-related issues. They should take about 1 hour and 30 minutes to
complete.
You will complete a breath test. For the breath test, you will blow into a tube that's
attached to a machine that is used to estimate the amount of tobacco smoke that you inhale.
You will be asked to provide 1 buccal (cheek cells) sample that will be collected using
mouthwash. Researchers will perform genetic tests with these samples to look for genes that
control the production and use of neurotransmitters, naturally occurring chemical messengers
in the brain. People with certain genes may have a more difficult time quitting smoking,
because of the way nicotine affects these chemicals. Genetic information obtained will not
be provided to you.
Your Height, Weight and Waist circumference measures will be taken.
You will also receive individual counseling. During counseling, you will discuss techniques
to help you quit smoking.
In addition, you will receive a small, hand-held personal computer and be trained in how to
use it. You will carry this computer with you for 4 weeks. You will use the computer to
answer questions about your mood, stress, and smoking-related issues. You will be asked to
fill out some questions on the computer each time you have an urge to smoke or you actually
smoke. Also, the computer will "beep" at random and set times and request that you answer
some questions. This computer will not wake you during the night and you will be able to
wait to answer questions for a few minutes if it goes off when you are busy. Answering the
questions should take about 5 to 10 minutes.
Third (Quit Day) and Fourth (Week 3) Study Visits:
Your Third visit (Quit Day) will occur 1 week after your Second (Baseline) visit. Your
Fourth visit will occur 3 weeks after your Quit Day. During these visits, you will be asked
to fill out questionnaires on a computer about your moods and feelings, as well as how many
cigarettes you smoke. The questionnaires should take about 30 minutes to complete.
You will also receive individual counseling. During counseling, you will discuss techniques
to help you quit smoking.
On your Third visit, you will complete the breath test and your Weight and Waist
circumference measures will also be taken.
At your Third visit you will be given a supply of nicotine patches to last until your Fourth
visit.
At your Fourth visit you will be given a one week supply of nicotine patches. You will be on
nicotine patches for a total of 4 weeks. At the Fourth Visit, you will also complete the
breath test, will give a saliva sample and your Weight and Waist circumference measures will
be taken.
Last (Week 26) Visit:
This visit will occur 26 weeks (or 6 months) after your Quit Day. During these visits, you
will be asked to fill out questionnaires on a computer about your moods and feelings, as
well as how many cigarettes you smoke.
The questionnaires should take about 1 1/2 hours to complete.
You will complete the breath test, your Weight and Waist circumference measures will be
taken and you will also give a saliva sample at the last (Week 26) visit.
Telephone Calls:
Between your first (Orientation) visit and your Fourth (Week 3) visit, you will receive 3
calls from a smoking cessation counselor. You will receive your first call a few days
before your quit day. You will receive a second call 1 week after your Quit Day and another
call 2 weeks after your Quit Day. During these calls, you will discuss techniques to help
you quit smoking. These calls will last 10 to 15 minutes and will be scheduled in advance.
Additional Information:
You may be contacted by mail, telephone, and/or e-mail throughout the study to remind you
about clinic visits. You may also be asked for information about your smoking status during
the usual reminder calls and/or calls to reschedule missed appointments.
Length of Study:
You will be considered off study when you complete the Week 26 (or Last) visit.
This is an investigational study. The nicotine patch is FDA approved and commercially
available. Up to 200 participants will take part in this study. All will be enrolled at M.
D. Anderson. |
| Criteria: |
|
Inclusion Criteria:
1. Current daily smoker who average >/= 5 cigarettes/day for the last year
2. Mexican-American (MA) Adults from the Houston-based MA Cohort Study
3. Age 18 to 65 years
4. Motivated to quit smoking in the next 30 days
5. Viable (working) telephone number and home address
6. Prefers to speak in Spanish
7. Register "8" or more on a carbon monoxide breath test
Exclusion Criteria:
1. Contraindication for nicotine patch use
2. Regular use of tobacco products other than cigarettes (cigars, pipes, smokeless
tobacco)
3. Use of nicotine replacement therapy products or other smoking cessation medications,
other than the nicotine patches supplied during the study
4. Pregnancy or lactation
5. Currently enrolled in a smoking cessation program
6. Participation in a smoking cessation program or study during the past 90 days
7. Another household member is enrolled in this protocol
8. Active substance abuse problem |
|
|
|
| Study is available at: |
|
UT MD Anderson Cancer Center
Houston, TX 77030
United States
Primary Contact:
David Wetter, PhD, MS, BA
Phone: 713-745-2682 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|